CLEC9A and pulmonary arterial hypertension: As in our Tnfaip3DNGR1-KO mouse model the Dngr1-cre-driven deletion mostly targets cDC1s, our findings indicate a key role of these cells in PAH development, which cannot be modulated by additional innate immune activation or defective BMPRII function in structural cells.